Karamvir Yadav, Medical Oncologist at Harish Renova Hospital, shared on X:
“ASCO Living Guideline 2026.1.3 – Multiple Myeloma Key update: eligible patients with R R MM should be considered for T – cell – redirecting therapies or triplet therapy, with treatment individualized according to prior exposure and disease characteristics. MajesTEC – 9, MonumenTAL – 3 and SUCCESSOR – 2 underpin important changes.”
Other articles featuring Karamvir Yadav on OncoDaily.